文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

重症COVID-19患者30天死亡率的预后因素:一项观察性队列研究

Prognostic Factors for 30-Day Mortality in Critically Ill Patients With Coronavirus Disease 2019: An Observational Cohort Study.
PubMed 文献 · Crit Care Med · 2021-01-01
一句话结论在英格兰、威尔士和北爱尔兰258个成人重症监护单元中,年龄、 ethnicity、 deprivation、BMI、既往依赖、免疫抑制、最低收缩压、最高心率、最高呼吸频率、PaO2/FiO2比值(与机械通气交互)、最高血乳酸、最高血清尿素和最低血小板计数与重症COVID-19患者30天死亡风险独立相关。

该观察性队列研究纳入2020年3月1日至6月22日期间英格兰、威尔士和北爱尔兰258个成人重症监护单元中10,362例确诊COVID-19并开始重症监护的患者,排除重症监护持续时间<24小时或核心变量缺失者后,9,990例纳入分析。主要结局为开始重症监护后30天内死亡时间;9,990例 eligible 患者(中位年龄60岁,70%男性)中3,933例在30天内死亡。采用多重插补和Cox比例风险模型多变量调整后,确定年龄、 ethnicity、 deprivation、BMI、既往依赖、免疫抑制、最低收缩压、最高心率、最高呼吸频率、PaO2/FiO2比值(与机械通气交互)、最高血乳酸、最高血清尿素和最低血小板计数与30天死亡风险显著相关;性别、镇静、最高体温和最低血红蛋白浓度无显著关联。这些发现可能支持开发预测模型用于重症监护提供者的基准比较。

要点

  • 多变量调整后,年龄、 ethnicity、 deprivation、BMI、既往依赖、免疫抑制与30天死亡风险显著相关。
  • 重症监护最初24小时内的最低收缩压、最高心率、最高呼吸频率、最高血乳酸、最高血清尿素和最低血小板计数与30天死亡风险显著相关。
  • PaO2/FiO2比值与30天死亡风险的关联和机械通气存在交互作用。
  • 性别、镇静、最高体温和最低血红蛋白浓度与30天死亡风险无显著关联。

适用人群与场景

  • 纳入:2020年3月1日至6月22日期间在英格兰、威尔士和北爱尔兰258个成人重症监护单元中确诊COVID-19并开始重症监护的成人患者。
  • 排除:重症监护持续时间<24小时或核心变量缺失的患者。
  • 最终纳入9,990例 eligible 患者(中位年龄60岁,70%男性)。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:观察性队列研究;样本量:10,362例开始重症监护,9,990例 eligible;中心数:258个成人重症监护单元;人群:英格兰、威尔士和北爱尔兰确诊COVID-19的成人重症监护患者。
  • 主要结局:开始重症监护后30天内死亡时间;9,990例 eligible 患者中3,933例在30天内死亡。
  • 多变量调整后,年龄、 ethnicity、 deprivation、BMI、既往依赖、免疫抑制、最低收缩压、最高心率、最高呼吸频率、PaO2/FiO2比值(与机械通气交互)、最高血乳酸、最高血清尿素和最低血小板计数与30天死亡风险显著相关。
  • 性别、镇静、最高体温和最低血红蛋白浓度与30天死亡风险无显著关联。
  • 截至2020年7月22日,189例仍在接受重症监护,446例仍在急性医院。
  • 预后因素缺失数据范围为0.1%至7.2%;采用完全条件规范进行十重插补,连续变量使用限制性立方样条建模。

证据类型、等级与局限

  • 证据类型:观察性队列研究。
  • 局限性:原文未述局限性。

对床旁实践的改变

  • 原文指出这些发现可能支持开发预测模型用于重症监护提供者的基准比较。

指南或共识出处

  • Crit Care Med

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: To identify characteristics that predict 30-day mortality among patients critically ill with coronavirus disease 2019 in England, Wales, and Northern Ireland.

DESIGN: Observational cohort study.

SETTING: A total of 258 adult critical care units.

PATIENTS: A total of 10,362 patients with confirmed coronavirus disease 2019 with a start of critical care between March 1, 2020, and June 22, 2020, of whom 9,990 were eligible (excluding patients with a duration of critical care less than 24 hr or missing core variables).

MEASUREMENTS AND MAIN RESULTS: The main outcome measure was time to death within 30 days of the start of critical care. Of 9,990 eligible patients (median age 60 yr, 70% male), 3,933 died within 30 days of the start of critical care. As of July 22, 2020, 189 patients were still receiving critical care and a further 446 were still in acute hospital. Data were missing for between 0.1% and 7.2% of patients across prognostic factors. We imputed missing data ten-fold, using fully conditional specification and continuous variables were modeled using restricted cubic splines. Associations between the candidate prognostic factors and time to death within 30 days of the start of critical care were determined after adjustment for multiple variables with Cox proportional hazards modeling. Significant associations were identified for age, ethnicity, deprivation, body mass index, prior dependency, immunocompromise, lowest systolic blood pressure, highest heart rate, highest respiratory rate, Pao2/Fio2 ratio (and interaction with mechanical ventilation), highest blood lactate concentration, highest serum urea, and lowest platelet count over the first 24 hours of critical care. Nonsignificant associations were found for sex, sedation, highest temperature, and lowest hemoglobin concentration.

CONCLUSIONS: We identified patient characteristics that predict an increased likelihood of death within 30 days of the start of critical care for patients with coronavirus disease 2019. These findings may support development of a prediction model for benchmarking critical care providers.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Ferrando-Vivas P, Doidge J, Thomas K, et al. Prognostic Factors for 30-Day Mortality in Critically Ill Patients With Coronavirus Disease 2019: An Observational Cohort Study. Crit Care Med. 2021. PMID: 33116052. doi:10.1097/CCM.0000000000004740

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。